Gastric and intestinal barrier impairment in tropical enteropathy and HIV: Limited impact of micronutrient supplementation during a randomised controlled trial

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Kelly, Paul ^a,b,c   Shawa, Tamara ^b   Mwanamakondo, Stayner ^b   Soko, Rose ^b   Smith, Geoff ^d   Barclay, G Robin ^e   Sanderson, Ian R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLGLUCOSE; ALPHA TOCOPHEROL; ANTIRETROVIRUS AGENT; ASCORBIC ACID; BETA CAROTENE; COLECALCIFEROL; COPPER; CYANOCOBALAMIN; FOLIC ACID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IODINE; IRON; LACTULOSE; LIPOPOLYSACCHARIDE; NICOTINIC ACID; PLACEBO; PYRIDOXINE; RHAMNOSE; RIBOFLAVIN; SELENIUM; THIAMINE; TRACE ELEMENT; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR P55; UNCLASSIFIED DRUG; XYLOSE; ZINC; ANTIBODY; RECOMBINANT HUMAN TUMOR NECROSIS FACTOR BINDING PROTEIN 1; RECOMBINANT HUMAN TUMOR NECROSIS FACTOR-BINDING PROTEIN-1; TUMOR NECROSIS FACTOR DECOY RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACHLORHYDRIA; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ATROPHY; BODY MASS; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; ENTEROPATHY; FECES ANALYSIS; FEMALE; GASTRIC ATROPHY; HELICOBACTER PYLORI; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SHIGELLOSIS; STOMACH PH; SUPPLEMENTATION; TABLET; URBAN POPULATION; ZAMBIA; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECT; FOLLOW UP; IMMUNOLOGY; INTESTINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PERMEABILITY; PH; STOMACH;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIBODIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HIV ENTEROPATHY; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; LIPOPOLYSACCHARIDES; MALE; MICRONUTRIENTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERMEABILITY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STOMACH; TUMOR NECROSIS FACTOR DECOY RECEPTORS; URBAN POPULATION; ZAMBIA;

EID: 77955108579     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-72     Document Type: Article

References (50)

1. Thapar N, Sanderson IR. Diarrhoea in children: an interface between developing and developed countries. Lancet 2004, 363:641-653. 10.1016/S0140-6736(04)15599-2, 14987892.
2. Attili SVS, Gulati AK, Singh VP, Varma DV, Rai M, Sundar S. Diarrhea, CD4 counts and enteric infections in a hospital-based cohort of HIV-infected patients around Varanasi, India. BMC Infect Dis 2006, 6:39. 10.1186/1471-2334-6-39, 1431539, 16509972.
3. Ghana VAST study team Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions and child mortality. Lancet 1993, 342:7-12. 10.1016/0140-6736(93)91879-Q, 8100345, Ghana VAST study team.
4. Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Syst Rev 2008, 16:CD005436.
5. Tielsch JM, Khatry SK, Stoltzfus RJ, Katz J, LeClerq SC, Adhikari R, Mullany LC, Black R, Shestra S. Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial. Lancet 2008, 370:1230-1239.
6. Fischer Walker CL, Black RE. Micronutrients and diarrheal disease. Clin Infect Dis 2007, 45(suppl 1):S73-77. 10.1086/518152, 17582575.
7. Irlam JH, Visser ME, Rollins N, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Syst Rev 2005, Issue 4:CD003650.
8. Friis H. Micronutrient interventions and HIV infection: a review of current evidence. Trop Med International Health 2006, 11:1849-1857.
9. Range N, Changalucha J, Krarup H, Magnussen P, Andersen AB, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomized two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr 2006, 95:762-70. 10.1079/BJN20051684, 16571156.
10. Burbano X, Miguez-Burbano MJ, McCollister K, Zhang G, Rodriguez A, Ruiz P, Lecusay R, Shor-Posner G. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials 2002, 3:483-491. 10.1310/A7LC-7C9V-EWKF-2Y0H, 12501132.
11. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ, Greeson JM, Baum MK, Shor-Posner G, Skyler JS, Schneiderman N. Suppression of HIV-1 viral load with selenium supplementation. Arch intern Med 2007, 167:148-154. 10.1001/archinte.167.2.148, 17242315.
12. Stephen AI, Avenell A. A systematic review of multivitamin and multimineral supplementation for infection. J Hum Nutr Dietet 2006, 19:179-190.
13. Hughes S, Kelly P. Interaction between malnutrition and immunity to parasites. Parasite Immunol 2006, 28:577-588. 1636690, 17042929.
14. Villamor E, Fawzi WW. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 2005, 18:446-464. 10.1128/CMR.18.3.446-464.2005, 1195969, 16020684.
15. Kelly P, Feakins R, Domizio P, Murphy J, Bevins CL, Wilson J, McPhail G, Bajaj-Elliot M, Poulsom R, Dhaliwal W. Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol 2004, 135:303-309. 10.1111/j.1365-2249.2004.02374.x, 1808949, 14738460.
16. Wiest R, Garcia-Tsao G. Bacterial translocation in cirrhosis. Hepatology 2005, 41:422-433. 10.1002/hep.20632, 15723320.
17. Balzan S, deA Quadros C, de Cleva R, Zilberstein B, Cecconnello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 2007, 22:464-471. 10.1111/j.1440-1746.2007.04933.x, 17376034.
18. Lata J, Jurankova J, Husova L, Senkyrik M, Dite P, Dastych M, Pribramska V, Kroupa R. Variceal bleeding in portal hypertension: bacterial infection and comparison of efficacy of intravenous and per-oral application of antibiotics - a randomized trial. Eur J Gastroenterol Hepatol 2005, 17:1105-1110. 10.1097/00042737-200510000-00015, 16148557.
19. Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, Kirk GD, Mehta SH, Cox AL, Thomas DL, Ray SC. HIV-related microbial translocation and progression of hepatitis C. Gastroenterology 2008, 135:226-233. 10.1053/j.gastro.2008.03.022, 2644903, 18457674.
20. Gatt M, Reddy BS, Macfie J. Review articles: bacterial translocation in the critically ill - evidence and methods of prevention. Aliment Pharmacol Therap 2007, 25:741-757.
21. Sanderson IR, Walker WA. Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update). Gastroenterology 1993, 104:622-639.
22. Lake-Bakaar G, Elsakr M, Hagag N, Lyubsky S, Ahuja J, Craddock B, Steigbigel RT. Changes in parietal cell structure and function in HIV disease. Dig Dis Sci 1996, 41:1398-408. 10.1007/BF02088565, 8689917.
23. Belitsos PC, Greenson JK, Yardley JH, Sisler JR, Bartlett JG. Association of gastric hypoacidity with opportunistic enteric infections in patients with AIDS. J Infect Dis 1992, 166:277-284.
24. Lim SG, Condez A, Lee CA, Johnson MA, Elia C, Poulter LW. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993, 92:448-454. 1554790, 8099858.
25. Schneider T, Jahn HU, Schmidt W, Riecken EO, Zeitz M, Ullrich R. Loss of CD4 lymphocytes in patients infected with HIV type 1 is more pronounced in the duodenal mucosa than in peripheral blood. Gut 1995, 37:524-529. 10.1136/gut.37.4.524, 1382905, 7489940.
26. Wang X, Rasmussen T, Pahar B, Poonia B, Alvarez X, Lackner AA, Veazey RS. Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 2007, 109:1174-1181. 10.1182/blood-2006-04-015172, 1785148, 17047153.
27. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008, 1:23-30. 10.1038/mi.2007.1, 2777614, 19079157.
28. Kelly P, Menzies I, Crane R, Zulu I, Nickols C, Feakins R, Mwansa J, Mudenda V, Katubulushi M, Greenwald S, Farthing MJG. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 2004, 70:412-419.
29. Kotler DP, Francisco A, Clayton F, Scholes JV, Orenstein JM. Small intestinal injury and parasitic diseases in AIDS. Ann Int Med 1990, 113:444-449.
30. Cummins AG, LaBrooy JT, Stanley DP, Roland R, Shearman DJC. Quantitative histological study of enteropathy associated with HIV infection. Gut 1990, 31:317-321. 10.1136/gut.31.3.317, 1378274, 2323596.
31. Greenson JK, Belitsos PC, Yardley JH, Bartlett JG. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med 1991, 114:366-372.
32. Kapembwa MS, Fleming SC, Sewankambo N, Serwadda D, Lucas S, Moody A, Griffin GE. Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci 1991, 81:327-334.
33. Keating J, Bjarnason I, Somasundaram S, Macpherson A, Francis N, Price AB, Sharpstone D, Smithson J, Menzies IS, Gazzard BG. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 1995, 37:623-629. 10.1136/gut.37.5.623, 1382865, 8549936.
34. Bjarnason I, Sharpstone DR, Francis N, Marker A, Taylor C, Barrett M, Macpherson A, Baldwin C, Menzies IR, Crane RC, Smith T, Pozniak A, Gazzard BG. Intestinal inflammation, ileal structure and function in HIV. AIDS 1996, 10:1385-1391. 10.1097/00002030-199610000-00011, 8902068.
35. Zulu I, Hassan G, Njobvu L, Dhaliwal W, Sianongo S, Kelly P. Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea. BMC Infect Dis 2008, 8:156. 10.1186/1471-2334-8-156, 2605754, 19014537.
36. Kelly P, Katubulushi M, Todd J, Banda R, Yambayamba V, Fwoloshi M, Zulu I, Kafwembe E, Yavwa F, Sanderson IR, Tomkins A. Micronutrient supplementation has a limited effect upon intestinal infectious disease and mortality in a Zambian population of mixed HIV status: a cluster randomized trial. Am J Clin Nutr 2008, 88:1010-17. 2777266, 18842788.
37. Department of Health Report 41 Dietary reference values for food energy and nutrients for the UK. The Stationery Office 1991, Department of Health Report 41.
38. Menzies IS, Zuckerman MJ, Nukajam WS, Somasundaram SG, Murphy B, Jenkins AP, Crane RS, Gregory GG. Geography of intestinal permeability and absorption. Gut 1999, 44:483-489. 10.1136/gut.44.4.483, 1727437, 10075954.
39. Stephens RC, Fidler K, Wilson P, Barclay GR, Mythen MG, Dixon GL, Turner MW, Klein NJ, Peters MJ. Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children. Intensive Care Med 2006, 32:286-94. 10.1007/s00134-005-0019-z, 16450100.
40. Hamilton-Davies C, Barclay GR, Cardigan RA, McDonald SJ, Purdy G, Machin SJ, Webb AR. Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery. Chest 1997, 112:1189-96. 10.1378/chest.112.5.1189, 9367456.
41. Fernando N, Holton J, Zulu I, Vaira D, Mwaba P, Kelly P. Helicobacter pylori infection in an urban Zambian population. J Clin Micro 2001, 39:1323-1327.
42. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-81. 10.1097/00000478-199610000-00001, 8827022.
43. Madan E, Kemp J, Westblom TV, Subik M, Sexton S, Cook J. Evaluation of stain methods for identifying Campylobacter pylori. American Journal Clinical Pathology 1988, 90:450-454.
44. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371. 10.1038/nm1511, 17115046.
45. Kostaki M, Fessatou S, Karpathios T. Refractory iron deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Paediatr 2003, 162:177-179.
46. Marignani M, Angeletti S, Bordi C, Malagnino F, Mancino C, Delle Fave G, Annibale B. Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol 1997, 32:617-622. 10.3109/00365529709025109, 9200297.
47. Sarker SA, Davidsson L, Mahmud H, Walczyk T, Hurrell RF, Gyr N, Fuchs G. Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi children. Am J Clin Nutr 2004, 80:149-153.
48. Batman PA, Miller ARO, Forster SM, Harris JRW, Pinching AJ, Griffin GE. Jejunal enteropathy associated with HIV infection: quantitative histology. J Clin Pathol 1989, 42:275-281. 10.1136/jcp.42.3.275, 1141868, 2703544.
49. Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, Schulzke JD. Impairment of the intestinal barrier is evident in untreated not absent in suppressively treated HIV-infected patients. Gut 2009, 58:220-227. 10.1136/gut.2008.150425, 18936106.
50. Batman PA, Kapembwa MS, Miller ARO, Sedgwick PM, Lucas S, Sewankando NK, Serwadda D, Pudney J, Moody A, Harris JR, Griffin GE. HIV enteropathy: comparative morphometry of the jejunal mucosa of HIV infected patients resident in the United Kingdom and Uganda. Gut 1998, 43:350-355. 10.1136/gut.43.3.350, 1727240, 9863480.